Investor notice: robbins llp informs stockholders of the class action lawsuit filed against cassava sciences, inc.

San diego , dec. 16, 2024 /prnewswire/ -- robbins llp announces that a class action was filed on behalf of all investors who purchased or otherwise acquired cassava sciences, inc. (nasdaq: sava) securities between february 7, 2024 and november 24, 2024. cassava is a clinical stage biotechnology company, with a focus on developing drugs for neurodegenerative diseases.
SAVA Ratings Summary
SAVA Quant Ranking